| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 512 |
| 1 | PREDNISONE | 240 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 236 |
| 3 | TACROLIMUS OINTMENT 0.1% | 234 |
| 4 | MYCOPHENOLATE MOFETIL | 217 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 217 |
| 6 | INSULIN GLARGINE | 214 |
| 7 | OMEPRAZOLE MAGNESIUM | 204 |
| 8 | DARBEPOETIN ALFA | 184 |
| 9 | ECULIZUMAB | 174 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUMASIRAN | 55 | 0.1425 |
| 1 | CYSTEAMINE BITARTRATE | 25 | 0.0238 |
| 2 | ALUMINUM HYDROXIDE GEL | 2 | 0.0136 |
| 3 | SODIUM CARBONATE | 3 | 0.0128 |
| 4 | PARICALCITOL | 168 | 0.0120 |
| 5 | AGALSIDASE BETA | 86 | 0.0092 |
| 6 | CYSTEAMINE HYDROCHLORIDE | 6 | 0.0091 |
| 7 | NITAZOXANIDE | 3 | 0.0086 |
| 8 | TOLVAPTAN | 114 | 0.0076 |
| 9 | DIFELIKEFALIN | 3 | 0.0073 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 399 |
| 1 | Corticosteroid [EPC] | 374 |
| 2 | Proton Pump Inhibitor [EPC] | 252 |
| 3 | Erythropoiesis-stimulating Agent [EPC] | 184 |
| 4 | Complement Inhibitor [EPC] | 176 |
| 5 | Vitamin D2 Analog [EPC] | 169 |
| 6 | Vitamin D Analog [EPC] | 168 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 167 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 153 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 128 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D2 Analog [EPC] | 169 | 0.0237 |
| 1 | Vitamin D Analog [EPC] | 168 | 0.0093 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 87 | 0.0089 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 114 | 0.0076 |
| 4 | Paramagnetic Contrast Agent [EPC] | 21 | 0.0046 |
| 5 | Potassium Binder [EPC] | 58 | 0.0039 |
| 6 | Erythropoiesis-stimulating Agent [EPC] | 184 | 0.0034 |
| 7 | Vitamin D3 Analog [EPC] | 66 | 0.0033 |
| 8 | Complement Inhibitor [EPC] | 176 | 0.0031 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 64 | 0.0030 |